We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.95%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$193B
AUM Growth
+$9.98B
Cap. Flow
+$5.76B
Cap. Flow %
2.98%
Top 10 Hldgs %
13.3%
Holding
8,497
New
756
Increased
3,610
Reduced
2,944
Closed
742

Sector Composition

Rank Sector Weight
1 Financials 7.75%
2 Healthcare 6.75%
3 Technology 6.26%
4 Industrials 5.06%
5 Consumer Discretionary 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAHC icon
7301
Phibro Animal Health
PAHC
$1.5B
$2K ﹤0.01%
59
-1,299
-96% -$42.4K
PSET icon
7302
Principal Exchange-Traded Funds Principal Quality ETF
PSET
$27.8M
$2K ﹤0.01%
61
PVBC
7303
DELISTED
Provident Bancorp
PVBC
$2K ﹤0.01%
202
-255
-56% -$2.68K
RFIL icon
7304
RF Industries
RFIL
$116M
$2K ﹤0.01%
1,000
-1,067
-52% -$1.72K
SHYF
7305
DELISTED
The Shyft Group
SHYF
$2K ﹤0.01%
173
-931
-84% -$7.87K
SLNO
7306
DELISTED
Soleno Therapeutics
SLNO
$2K ﹤0.01%
+58
New +$2.69K
SSTI icon
7307
SoundThinking
SSTI
$108M
$2K ﹤0.01%
+161
New +$2.21K
STRT icon
7308
STRATTEC Security
STRT
$376M
$2K ﹤0.01%
48
-608
-93% -$19.1K
TANH icon
7309
Tantech Holdings
TANH
$5.96M
0
TNXP icon
7310
Tonix Pharmaceuticals
TNXP
$152M
0
TPIC
7311
DELISTED
TPI Composites
TPIC
$2K ﹤0.01%
90
-166
-65% -$2.99K
TROO icon
7312
TROOPS Inc
TROO
$202M
$2K ﹤0.01%
1,885
-4,647
-71% -$7.82K
USIO icon
7313
Usio Inc
USIO
$54.4M
$2K ﹤0.01%
+1,342
New +$1.88K
TGEN
7314
Tecogen Inc
TGEN
$89.8M
$2K ﹤0.01%
645
-1,655
-72% -$5.94K
WHLM
7315
DELISTED
Wilhelmina International, Inc
WHLM
$2K ﹤0.01%
249
+160
+180% +$1.13K
MMAT
7316
DELISTED
Meta Materials Inc. Common Stock
MMAT
$2K ﹤0.01%
+6
New +$1.75K
OPGN
7317
DELISTED
OpGen, Inc
OPGN
0
NBSE
7318
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$2K ﹤0.01%
10
-20
-67% -$5.37K
FGH
7319
DELISTED
FG Group Holdings Inc.
FGH
$2K ﹤0.01%
250
-1,523
-86% -$9.72K
DMK
7320
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$2K ﹤0.01%
7
FRTX
7321
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$2K ﹤0.01%
3
+1
+50% +$731
MLPO
7322
DELISTED
Credit Suisse S&P MLP Index ETN
MLPO
$2K ﹤0.01%
+111
New +$1.84K
TRHC
7323
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$2K ﹤0.01%
115
-1,546
-93% -$20.9K
SNLN
7324
DELISTED
Highland/iBoxx Senior Loan ETF
SNLN
$2K ﹤0.01%
+106
New +$1.96K
ISEE
7325
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$2K ﹤0.01%
730
-109
-13% -$297

Similar funds

UBS Group's Q2 2017 Portfolio in Review

As of Q2 2017, UBS Group held 8,497 positions worth $193B, up 5.4% from $183B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q2 2017 filing shows 756 new, 3,610 increased, 2,944 reduced and 742 closed positions. Its largest new stake was Ultra Petroleum Corp. Common Stock: 3,128,785 shares worth $33.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $3.06B.

By sector, the portfolio is most concentrated in Financials at 7.7% of assets, up from 7.4% a quarter earlier, followed by Healthcare and Technology.

  • UBS Group's largest Q2 2017 buy was Ultra Petroleum Corp. Common Stock: 3,128,785 shares worth $33.9M.
  • UBS Group added most to Monsanto Co in Q2 2017, an estimated $622M increase.
  • UBS Group's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.06B.
  • UBS Group fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $383M.
  • UBS Group's ten largest holdings make up 13% of its $193B portfolio in Q2 2017.
  • UBS Group opened 756 new positions and closed 742 in Q2 2017.
  • UBS Group's portfolio value rose 5.4% quarter-over-quarter to $193B.

Based on UBS Group's 13F filing for Q2 2017, filed 14 Aug 2017.